Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,650.66 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -6.9571
Revenue (TTM): $0.77 M
Dividend Yield: N/A%
ROE: -28.35%
Latest News
-
Agios Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
Fri, Feb 13, 2026 2:01 AM
-
Agios Pharmaceuticals Files Prospectus For Offering Mixed Shelf; Terms Not Disclosed
Thu, Feb 12, 2026 5:21 PM
-
Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call Transcript
Thu, Feb 12, 2026 5:04 PM
-
HC Wainwright & Co. Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $65
Thu, Feb 12, 2026 3:01 PM
-
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Q4 2025 Revenue Beat and Narrower Loss
Thu, Feb 12, 2026 12:21 PM
-
Earnings Summary: Agios Pharmaceuticals Q4
Thu, Feb 12, 2026 7:36 AM
-
Agios Pharmaceuticals Q4 EPS $(1.86) Beats $(1.94) Estimate, Sales $19.967M Beat $12.014M Estimate
Thu, Feb 12, 2026 7:35 AM
-
Earnings Scheduled For February 12, 2026
Thu, Feb 12, 2026 7:11 AM
Key Financials
Financial data not available
